EDITOR,—We applaud E Lidbrink and colleagues' attempts to quantify the substantial disadvantages of false positive findings in patients invited to attend for breast screening.1 Clearly, a financial cost of over £250000 from a single round of screening at a well organised centre in Stockholm represents a huge sum …
No takes yet. Share an insight, caveat, or question.
Tobias et al. (1996) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: